| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 08/05/2024 | 22:30 | Business Wire | Alcon Announces Results of 2024 Annual General Meeting | NYSE:ALC | Alcon Inc |
| 01/05/2024 | 15:45 | Business Wire | Algoma Central Corporation Reports Financial Results for the 2024 First Quarter | NYSE:ALC | Alcon Inc |
| 07/04/2024 | 23:59 | Business Wire | Alcon Publishes Agenda for 2024 Annual General Meeting | NYSE:ALC | Alcon Inc |
| 12/03/2024 | 09:30 | Business Wire | Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India | NYSE:ALC | Alcon Inc |
| 06/03/2024 | 15:55 | Business Wire | Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone | NYSE:ALC | Alcon Inc |
| 06/03/2024 | 15:55 | Business Wire | Vivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implants | NYSE:ALC | Alcon Inc |
| 02/03/2024 | 00:44 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
| 27/02/2024 | 22:30 | Business Wire | Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 | NYSE:ALC | Alcon Inc |
| 26/02/2024 | 13:00 | Business Wire | Algoma Central Corporation Reports Financial Results for Fiscal 2023 | NYSE:ALC | Alcon Inc |
| 12/02/2024 | 22:22 | Business Wire | Algoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024 | NYSE:ALC | Alcon Inc |
| 01/02/2024 | 19:04 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:ALC | Alcon Inc |
| 01/02/2024 | 15:02 | Business Wire | Alcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytie | NYSE:ALC | Alcon Inc |
| 18/01/2024 | 14:54 | Business Wire | Algoma Central Corporation continues to grow product tanker business with the acquisition of two additional vessels | NYSE:ALC | Alcon Inc |
| 10/01/2024 | 10:12 | Dow Jones News | Alcon Shares Rise After Dry-Eye Care Drug Shows Promising Results | NYSE:ALC | Alcon Inc |
| 09/01/2024 | 23:20 | Dow Jones News | Alcon Reports Results for Dry-Eye-Treatment Trials | NYSE:ALC | Alcon Inc |
| 09/01/2024 | 22:30 | Business Wire | Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye | NYSE:ALC | Alcon Inc |
| 05/01/2024 | 14:00 | GlobeNewswire Inc. | Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements | NYSE:ALC | Alcon Inc |
| 27/12/2023 | 15:01 | Business Wire | Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference | NYSE:ALC | Alcon Inc |
| 15/11/2023 | 17:08 | Dow Jones News | Alcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data Talk | NYSE:ALC | Alcon Inc |
| 15/11/2023 | 12:11 | Dow Jones News | Alcon's Swiss Shares Drop After Guidance Narrowed to Lower End of Range | NYSE:ALC | Alcon Inc |
| 14/11/2023 | 22:30 | Business Wire | Alcon Reports Third Quarter 2023 Results | NYSE:ALC | Alcon Inc |
| 08/11/2023 | 15:03 | Business Wire | Alcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytie | NYSE:ALC | Alcon Inc |
| 03/11/2023 | 20:00 | Business Wire | Algoma Central Corporation Reports Financial Performance for the 2023 Third Quarter | NYSE:ALC | Alcon Inc |
| 30/10/2023 | 14:01 | Business Wire | Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023 | NYSE:ALC | Alcon Inc |
| 27/10/2023 | 13:00 | Business Wire | Algoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023 | NYSE:ALC | Alcon Inc |
| 10/10/2023 | 14:01 | Business Wire | Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia | NYSE:ALC | Alcon Inc |
| 14/09/2023 | 13:00 | Business Wire | Algoma Central Corporation and Furetank Co-Order Two Additional Newbuilds | NYSE:ALC | Alcon Inc |
| 09/09/2023 | 07:01 | Business Wire | Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence | NYSE:ALC | Alcon Inc |
| 06/09/2023 | 22:30 | Business Wire | Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams | NYSE:ALC | Alcon Inc |
| 15/08/2023 | 22:31 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:ALC | Alcon Inc |